Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gauvin

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Nutrition, Health & Aging|May 3, 2013
Baseline determinants of global diet quality in older men and women from the NuAge cohortB Shatenstein, L Gauvin, H Keller, et al.
Thrombosis Research|August 30, 2025
The role of 12-lipoxygenase in regulating megakaryocyte maturation and platelet-like particles productionVanessa L Gauvin, Marie-France N Soucy, Jaël D Richard, et al.
Investigational New Drugs|April 4, 2018
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumorsCarol Aghajanian, Katherine M Bell-McGuinn, Howard A Burris, et al.
International Immunopharmacology|June 9, 2023
Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human plateletsMathieu P A Hébert, Ayyoub Selka, Andréa A Lebel, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Nutrition, Health & Aging|May 3, 2013
Baseline determinants of global diet quality in older men and women from the NuAge cohortB Shatenstein, L Gauvin, H Keller, et al.
Thrombosis Research|August 30, 2025
The role of 12-lipoxygenase in regulating megakaryocyte maturation and platelet-like particles productionVanessa L Gauvin, Marie-France N Soucy, Jaël D Richard, et al.
Investigational New Drugs|April 4, 2018
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumorsCarol Aghajanian, Katherine M Bell-McGuinn, Howard A Burris, et al.
International Immunopharmacology|June 9, 2023
Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human plateletsMathieu P A Hébert, Ayyoub Selka, Andréa A Lebel, et al.
Pageof 5